Published in Maturitas on July 01, 1984
Induction of sex hormone binding globulin by phenytoin. Br Med J (1977) 2.13
Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 1.75
Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) (1971) 1.57
The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey. Contraception (1976) 1.47
Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol (1971) 1.38
Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol (Copenh) (1972) 1.12
Women's attitudes to being asked about exposure to violence. Midwifery (2001) 1.09
Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab (1967) 1.09
The vaginal epithelium in the postmenopause--cytology, histology and pH as methods of assessment. Maturitas (1995) 1.06
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) (1982) 1.04
Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology. Fertil Steril (1991) 1.03
Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand (1983) 1.02
Progesterone level and response to oxytocin at term. Lancet (1968) 1.00
The round ligament: a target organ for steroid hormones. Gynecol Endocrinol (1993) 0.99
Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl (1974) 0.97
Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens. Acta Endocrinol (Copenh) (1971) 0.96
Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology (1968) 0.95
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci (1979) 0.95
Oral contraceptives after intestinal bypass operations. JAMA (1976) 0.93
Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. Acta Endocrinol (Copenh) (1971) 0.93
Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 0.92
Sex hormone binding globulin: the carrier protein for d-norgestrel. J Clin Endocrinol Metab (1976) 0.92
The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90
Menstruation span--a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand (1986) 0.90
The prevalence of violence investigated in a pregnant population in Sweden. J Psychosom Obstet Gynaecol (2001) 0.90
Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study. Maturitas (1992) 0.90
Radioimmunological methods for the estimation of oestrone, oestradiol-17beta and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl (1974) 0.89
Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol (1993) 0.89
Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstet Gynecol Scand (1991) 0.88
Monophasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol (1972) 0.87
DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short term results. Acta Obstet Gynecol Scand (1999) 0.86
Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period. Contraception (1975) 0.86
A simplified procedure for the assay of progesterone. Acta Endocrinol Suppl (Copenh) (1970) 0.86
Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas (1996) 0.86
The influence of conjugated estrogens in radioimmunoassays using different antibodies against estradiol-17beta. Steroids (1973) 0.86
Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II. Acta Obstet Gynecol Scand (1983) 0.85
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynaecol (1978) 0.84
Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent. Contraception (1973) 0.84
The influence of norethisterone oenanthate on ovarian function. Acta Endocrinol (Copenh) (1976) 0.84
Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Invest (1990) 0.83
Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril (1980) 0.83
Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology (1969) 0.83
Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol (1980) 0.83
A D-norgestrel-releasing IUD. Contraception (1976) 0.82
Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception (1976) 0.82
Transfer of estradiol to human milk. Am J Obstet Gynecol (1978) 0.82
Serum estrogens and androgens in women with endometrial carcinoma. Gynecol Oncol (1986) 0.81
Ovarian function during use of a levonorgestrel-releasing IUD. Contraception (1990) 0.81
Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Acta Obstet Gynecol Scand (1977) 0.81
Periovulatory levels of plasma progesterone and luteinizing hormone in women. Acta Endocrinol (Copenh) (1969) 0.81
Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device. Am J Obstet Gynecol (1973) 0.80
Peripheral plasma levels of oestrone and progesterone in pregnant cows treated with dexamethasone. Acta Endocrinol (Copenh) (1972) 0.80
Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin. Am J Obstet Gynecol (1973) 0.80
Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium. Contraception (1980) 0.79
Influence of hypophysectomy, sham hypophysectomy and other surgical procedures on luteal function in the rhesus monkey. Endocrinology (1968) 0.79
Peripheral plasma levels of 17 -hydroxyprogesterone, progesterone and oestradiol during normal menstrual cycles in women. Acta Endocrinol (Copenh) (1972) 0.79
Peripheral plasma levels of oestrogens and progesterone during late bovine pregnancy. Acta Endocrinol (Copenh) (1973) 0.79
The sterile menstrual cycle. The driving force behind pathology in the reproductive organs. Acta Obstet Gynecol Scand Suppl (1984) 0.79
Levonorgestrel plasma levels during continuous administration with different models of subdermal implants. Contraception (1983) 0.79
Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants. Contraception (1988) 0.79
Plasma levels of levonorgestrel in women during longterm use of norplant. Contraception (1981) 0.79
Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375). Acta Obstet Gynecol Scand (1975) 0.79
Sialic acid content and sperm penetration of cervical mucus in relation to total urinary oestrogen excretion and plasma progesterone levels in ovulatory women. Acta Endocrinol (Copenh) (1969) 0.79
Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2). Contraception (1987) 0.78
Blood plasma levels of progesterone and oestradiol in the dog during the oestrous cycle and pregnancy. Acta Endocrinol (Copenh) (1975) 0.78
Endocrine changes before and after the menarche. I. Urinary excretion of estrogen, FSH and LH, and serum levels of progesterone, FSH and LH. Acta Obstet Gynecol Scand (1974) 0.78
Levels of progesterone in peripheral plasma during the menstrual cycle of the rhesus monkey. Endocrinology (1967) 0.78
Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in Rhesus monkeys. Int J Fertil (1974) 0.78
Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy. Contraception (1985) 0.78
Relation between sex hormone binding globulin and D-norgestrel levels in plasma. Acta Endocrinol (Copenh) (1977) 0.78
Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol (1978) 0.78
Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally. Contraception (1976) 0.78
Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles. Contraception (1976) 0.78
Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal. Acta Obstet Gynecol Scand (1984) 0.78
A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception (2000) 0.78
Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas (1993) 0.78
Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol. Clin Endocrinol (Oxf) (1979) 0.78
Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden. Contraception (1988) 0.78
Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera. Contraception (1976) 0.78
Transvaginal ultrasonographic evaluation of the endometrium related to the histological findings in pre- and perimenopausal women. Gynecol Obstet Invest (1998) 0.78
Progesterone levels in amniotic fluid and plasma from women. I. Levels during normal pregnancy. Acta Obstet Gynecol Scand (1971) 0.77
The prevalence of urogenital symptoms in postmenopausal women. Maturitas (1995) 0.77
Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation. Acta Pharmacol Toxicol (Copenh) (1986) 0.77
Treatment of primary amenorrhoea with human pituitary and chorionic gonadotrophins. J Obstet Gynaecol Br Commonw (1970) 0.77
Assessment of placental function in uncomplicated and complicated late pregnancy by estimation of unconjugated oestrogens in plasma after an intravenous injection of dehydroepiandrosterone sulphate. Acta Endocrinol (Copenh) (1978) 0.77
Low-dose 17 beta-oestradiol during maintenance therapy--a pharmacokinetic and pharmacodynamic study. Maturitas (1995) 0.76
Peripheral plasma levels of oestrogens, progesterone and 17alpha-hydroxyprogesterone during gestation in the rhesus monkey. Acta Endocrinol (Copenh) (1973) 0.76
The effect of oxytocin on the complication rate of early therapeutic abortions. Acta Obstet Gynecol Scand (1970) 0.76
The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses. Acta Obstet Gynecol Scand (1984) 0.76
Ethinyl estradiol in human milk and plasma after oral administration. Contraception (1978) 0.76
Peripheral plasma levels of oestrone, oestradiol-17beta and progesterone during ovulatory menstrual cycles in the rhesus monkey with special reference to the onset of menstruation. Acta Endocrinol (Copenh) (1973) 0.76
Bioavailability of oestriol. Acta Endocrinol (Copenh) (1982) 0.76
The effect of progestin R 2323 released from vaginal rings on ovarian function. Contraception (1975) 0.76
New kinetic data on estradiol in light of the vaginal ring concept. Maturitas (1995) 0.76
Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study. Acta Obstet Gynecol Scand Suppl (1981) 0.76
Peripheral plasma levels of oestrogens, progesterone and 17 -hydroxyprogesterone during the menstrual cycle of the rhesus monkey. Acta Endocrinol (Copenh) (1972) 0.75
Postovulatory contraception in women with large doses of norethindrone. Contraception (1972) 0.75
Long-term follow-up of women treated with Norplant implants. Contraception (1987) 0.75
Transvaginal sonography of the internal genital organs in postmenopausal women on low-dose estrogen treatment. Ultrasound Obstet Gynecol (1994) 0.75